Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Lebrikizumab in Adults with Asthma Uncontrolled on Inhaled Corticosteroids
2009-010359-28Phase 2Completed
- Sponsor
- Roche
- Start
- Jun 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing Lebrikizumab with Placebo (2 arms). Primary endpoint: Primary efficacy outcome. Started Jun 2009; status: completed.
02
Drugs
lebrikizumab
03
Conditions
asthma
Beyond the preview
Go deeper on 2009-010359-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010359-28.